https://proqr-tx.com
ProQR Therapeutics B.V. is a biopharmaceutical firm based in The Netherlands that is developing RNA-based therapeutics for treating severe genetic disorders. The company plans to offer 6.3 million shares in a price range of $11 to $13 a share. Gross proceeds would be about $75 million at a market cap of around $252 million. The shares are expected to price on Wednesday and begin trading Thursday on the Nasdaq under the ticker symbol PRQR.
- Forums
- ASX - By Stock
- BLT
- New rnai company
New rnai company
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online